Concurrent Azeliragon With Craniospinal Irradiation

Clinical trial NCT06724926 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06724926
Sponsor: NYU Langone Health
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor High-grade Glioma Leptomeningeal Metastasis

Start date: 2025-02-18
Primary completion: 2027-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.